Higher Risks for Artificially Conceived Infants
By Miriam Zoll, <i>Biopolitical Times</i> guest contributor
| 03. 12. 2014
Data about the risks involved in high-tech assisted reproduction have until recently been scarce. The industry naturally touts success rates and downplays failures, and the Centers for Disease Control and Prevention (CDC) has largely been restricted to sharing only self-reported data from clinics with the public. But this is changing—and families intending to use these technologies should be aware of the full implications of the statistics that are available.
Last month, for instance, the Society for Assisted Reproductive Technologies announced that a record number of babies were born – 61,740 – as a result of the 165,172 in vitro fertilization (IVF) cycles performed at 379 of its member clinics in 2012.1
On the surface, this announcement may be perceived as an endorsement for the success of reproductive medical services that have, undoubtedly, helped many couples over the last 35 years to bear the children they might otherwise not have been able to. As we celebrate the births of these babies, however, it is also important to recognize that the vast majority of IVF cycles continue to fail, and that...
Related Articles
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...